ArticleEye (London, England)2026
Ophthalmic dispensing patterns in New Zealand: a ten-year review.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAimed to examine national dispensing patterns of ophthalmic medications in New Zealand over a ten-year period, focusing on demographic and regional variation.
methodsThis nationwide population-level retrospective study analysed dispensing data for all Pharmaceutical Management Agency (PHARMAC)-subsidised ophthalmic medications between 1-January-2012 to 31-December-2021. Medications were classified into seven classes. Dispensing rates were compared by age, gender, ethnicity, and region.
results10,941,081 dispensing events were recorded, increasing by 36% from 2012 to 2021. Chloramphenicol, Latanoprost, and Hypromellose with Dextran were the most dispensed agents. Anti-infective agents were mostly dispensed to the youngest and oldest age groups, dry eye and anti-inflammatory agents were dispensed mostly to females, and glaucoma medications were predominantly dispensed to older individuals. Age-adjusted rates demonstrated inequities for Māori, who accounted for 16.5% of the population but only 8% of dispensing events. Māori had consistently lower dispensing rates across most medication classes compared to European and the other ethnicity group, which included individuals identifying as any ethnicity other than Māori, European, or Pasifika, including Asian, Middle Eastern, Latin American, African, and all other ethnicities. Variation by geographic region was noted, with six of 20 regions exceeding the national mean dispensing rate of 246.42 per 1000 population per year.
conclusionA substantial increase in dispensing of ophthalmic medications occurred in New Zealand over this 10-year period with significant variation by demographics. The inequity in dispensing rates for Māori is concerning and may contribute to healthcare inequity. These findings affirm the need for targeted strategies to improve equitable access to ophthalmic care and medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.